C. Hare

发表

Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation

C. B. Hare, J. Volk, L. Hurley, 2016, Journal of acquired immune deficiency syndromes.

No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

C. B. Hare, J. Volk, D. Nguyen, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings

C. B. Hare, J. Volk, Al Liu, 2016, Current HIV/AIDS Reports.

Incident Hepatitis C Virus Infections Among Users of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

C. B. Hare, J. Volk, J. Marcus, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Early Adopters of Event-driven Human Immunodeficiency Virus Pre-exposure Prophylaxis in a Large Healthcare System in San Francisco.

J. Volk, L. Hurley, D. Satre, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV

C. B. Hare, J. Lam, D. Satre, 2022, AIDS and Behavior.

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV

C. B. Hare, J. Volk, D. Satre, 2019, Sexually Transmitted Infections.

Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV

J. Lam, D. Satre, M. Silverberg, 2022, Aids and Behavior.

Disparities in Uptake of HIV Preexposure Prophylaxis in a Large Integrated Health Care System.

J. Volk, L. Hurley, M. Silverberg, 2016, American journal of public health.

Testing and linkage to care outcomes for a clinician-initiated rapid HIV testing program in an urban emergency department.

D. Dowdy, M. Roemer, K. Christopoulos, 2011, AIDS patient care and STDs.

Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.

C. B. Hare, H. Günthard, D. Havlir, 2010, The Journal of infectious diseases.

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

D. Nixon, F. Hecht, J. Levy, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting.

C. B. Hare, J. Kahn, D. Havlir, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparison of characteristics of treated and non‐treated patients with Hepatitis C infection

C. B. Hare, W. Klaskala, V. Gotz, 2006, Pharmacoepidemiology and drug safety.

Clinical experience with nonstandard doses ofinterferon alfa-2b and ribavirin in the treatment of chronic hepatitis C infection: A retrospective analysis.

C. B. Hare, W. Klaskala, V. Gotz, 2005, Current therapeutic research, clinical and experimental.

The Deadliest Catch: Fishing for HIV in New Waters

C. Pilcher, C. Hare, 2008, Annals of Internal Medicine.

Age group differences in substance use, social support, and physical and mental health concerns among people living with HIV two years after receiving primary care-based alcohol treatment

C. B. Hare, J. Lam, D. Satre, 2022, Aging & mental health.

A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence

J. Klausner, S. Shoptaw, W. King, 2006, BMC public health.

The Essentials of HIV: A Review for Nurses

C. B. Hare, S. Pinkerton, A. Petroll, 2008, Journal of infusion nursing : the official publication of the Infusion Nurses Society.

Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the promoting access to care engagement (PACE) trial.

P. Volberding, S. Slome, M. Horberg, 2019, Contemporary clinical trials.

The effect of AIDS Clinical Trials Group Protocol 5164 on the time from Pneumocystis jirovecii pneumonia diagnosis to antiretroviral initiation in routine clinical practice: a case study of diffusion, dissemination, and implementation.

M. Petersen, D. Havlir, S. Deeks, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system

Kristin L. Sainani, R. Shafer, S. Rhee, 2022, PloS one.

Geriatric Assessments and Association With VACS Index Among HIV-Infected Older Adults in San Francisco

N. Hessol, J. Bourgeois, M. Gandhi, 2016, Journal of acquired immune deficiency syndromes.

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

P. Volberding, M. Horberg, J. Lam, 2019, Journal of General Internal Medicine.

Changes in Days of Unhealthy Alcohol Use and Antiretroviral Therapy Adherence, HIV RNA Levels, and Condomless Sex: A Secondary Analysis of Clinical Trial Data

M. Horberg, E. Williams, S. Catz, 2019, AIDS and Behavior.

Adverse childhood experiences, mental health, substance use, and HIV-related outcomes among persons with HIV

B. McCaw, D. Satre, Stacy A Sterling, 2019, AIDS care.

HIV Stigma and Its Associations with Longitudinal Health Outcomes Among Persons Living with HIV with a History of Unhealthy Alcohol Use

E. Williams, D. Satre, Stacy A Sterling, 2020, AIDS and Behavior.

Simplifying Consent for HIV Testing Is Associated with an Increase in HIV Testing and Case Detection in Highest Risk Groups, San Francisco January 2003–June 2007

J. Klausner, M. Katz, G. Colfax, 2008, PloS one.

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients.

C. B. Hare, D. Havlir, P. Tien, 2006, Journal of acquired immune deficiency syndromes.

Primary HIV infection

C. B. Hare, J. Kahn, C. Hare, 2004, Current infectious disease reports.

Low Rates of Hepatitis Screening and Vaccination of HIV-Infected MSM in HIV Clinics

C. B. Hare, C. Kent, K. Workowski, 2012, Sexually transmitted diseases.

A Pharmacist‐Led Program to Evaluate and Reduce Polypharmacy and Potentially Inappropriate Prescribing in Older HIV‐Positive Patients

C. B. Hare, M. Gandhi, Edgar Pierluissi, 2017, Pharmacotherapy.

Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic

C. B. Hare, D. Havlir, D. Dowdy, 2011, Journal of acquired immune deficiency syndromes.

Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: Baseline findings from the Health & Motivation study.

M. Horberg, S. Catz, D. Satre, 2018, Addictive behaviors.

Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care

C. B. Hare, Vanessa A. Palzes, J. Flamm, 2022, AIDS and Behavior.

Health System-Based Unhealthy Alcohol Use Screening and Treatment Comparing Demographically-Matched Participants With and Without HIV.

C. B. Hare, J. Sterne, A. Justice, 2020, Alcoholism, clinical and experimental research.

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals.

C. B. Hare, K. Tashima, S. Little, 2012, The Journal of infectious diseases.

Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens

C. B. Hare, Kristin L. Sainani, R. Shafer, 2020, Open forum infectious diseases.

HIV Infection and Drug Resistance with Unsupervised Use of HIV Pre-Exposure Prophylaxis.

J. Volk, D. Nguyen, J. Marcus, 2017, AIDS research and human retroviruses.

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

C. B. Hare, H. Günthard, D. Havlir, 2010, AIDS.

Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital

C. Dawson-Rose, C. Pilcher, Mallory O. Johnson, 2013, PloS one.

Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy.

C. B. Hare, D. Havlir, J. Mellors, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Methamphetamine Use, Transmission Risk Behavior and Internet Use Among HIV-Infected Patients in Medical Care, San Francisco, 2008

J. Klausner, C. Marquez, M. John, 2010, AIDS and Behavior.

Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006

J. Klausner, C. Marquez, M. John, 2009, AIDS care.

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.

L. Hurley, M. Silverberg, Scott, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter.

C. B. Hare, D. Havlir, M. Pandori, 2011, Journal of virological methods.

Viral hepatitis in Hawai'i--differing perspectives.

C. Leevy, M. Bannan, W. Haning, 2010, Hawaii medical journal.

Simvastatin-nelfinavir interaction implicated in rhabdomyolysis and death.

C. B. Hare, H. Lampiris, C. Grunfeld, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Therapeutic efficacy of the topoisomerase I inhibitor 7-ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against pediatric and adult central nervous system tumor xenografts

C. B. Hare, S. Keir, D. Bigner, 1996, Cancer Chemotherapy and Pharmacology.

Partnership 2-1-2013 Leveraging a Rapid , Round-the-Clock HIV Testing System to Screen for Acute HIV Infection in a Large Urban Public Medical Center

C. B. Hare, M. Pandori, J. Klausner, 2016 .

Mental health and substance use screening in HIV primary care before and during the early COVID-19 pandemic

J. Flamm, D. Satre, M. Silverberg, 2023, BMC Health Services Research.

Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department.

D. Dowdy, R. Rodriguez, B. Kaplan, 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Reply to DiNubile

D. Havlir, C. Hare, 2008 .

Characterization of the mechanisms of busulfan resistance in a human glioblastoma multiforme xenograft

C. B. Hare, S. Keir, D. Bigner, 1997, Cancer Chemotherapy and Pharmacology.

Personal health records in a public hospital: experience at the HIV/AIDS clinic at San Francisco General Hospital

Joan F. Hilton, C. Bradley Hare, James S. Kahn, 2010, J. Am. Medical Informatics Assoc..

Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents

C. B. Hare, S. Keir, D. Bigner, 1998, Cancer Chemotherapy and Pharmacology.

Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006–2007

J. Klausner, S. Philip, K. Bernstein, 2009, BMC public health.

The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

D. Richman, F. Vaida, S. Little, 2010, The Journal of infectious diseases.

Interventions to Reduce Unhealthy Alcohol Use among Primary Care Patients with HIV: the Health and Motivation Randomized Clinical Trial

P. Volberding, M. Horberg, S. Catz, 2019, Journal of General Internal Medicine.